This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Benjamin Fulton: Innovator in Antibody Development
Introduction
Benjamin Fulton is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for viral infections. His work is crucial in the ongoing fight against coronaviruses.
Latest Patents
Fulton holds a patent for "Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments." This patent provides antibodies and antigen-binding fragments that specifically bind to a coronavirus spike protein. The methods described in the patent are aimed at treating or preventing viral infections, including those caused by coronaviruses. He has 1 patent to his name.
Career Highlights
Benjamin Fulton is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Regeneron has positioned him at the forefront of research in antibody therapies.
Collaborations
Fulton collaborates with talented professionals in his field, including Alina Baum and Christos Kyratsous. Their combined expertise enhances the research and development efforts at Regeneron.
Conclusion
Benjamin Fulton is a key figure in the development of antibody therapies for viral infections. His innovative work and collaborations contribute significantly to advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile